CLINICAL_TRIALS
trial_result
· 2014-12-02
Clinical Trial Update: ASCT for Relapsed APL After Molecular Remission [Phase 2]
Summary
A Phase 2 trial evaluating autologous stem cell transplantation for relapsed Acute Promyelocytic Leukemia after molecular remission was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Promyelocytic Leukemia, Relapse | Phase 2 | Status: TERMINATED